Comparison of the 20-Hour Intravenous and 72-Hour Oral Acetylcysteine Protocols for the Treatment of Acute Acetaminophen Poisoning

Annals of Emergency Medicine

Volumn 54, Issue 4, 2009, Pages 606-614

  Yarema, Mark C ^a,b   Johnson, David W ^a,b   Berlin, Randall J ^a   Sivilotti, Marco L A ^c,d   Nettel Aguirre, Alberto ^a,b   Brant, Rollin F ^e   Spyker, Daniel A ^f   Bailey, Benoit ^g   Chalut, Dominic ^h   Lee, Jacques S ^i,j   Plint, Amy C ^k   Purssell, Roy A ^e,l   Rutledge, Tim ^j   Seviour, Catherine A ^m   Stiell, Ian G ^k   Thompson, Margaret ^d,j   Tyberg, Jeffrey ^i,j   Dart, Richard C ⁿ   Rumack, Barry H ^o  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d Ontario Poison Centre   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MONTREAL   (Canada)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF OTTAWA   (Canada)

^l Drug and Poison Information Centre   (Canada)

^m MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁿ ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^o Children's Hospital Colorado   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

ADULT; ANAPHYLAXIS; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG INTOXICATION; DRUG OVERDOSE; FATALITY; FEMALE; FLUSHING; HUMAN; HYPOTENSION; LIVER GRAFT; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN EDEMA; SKIN MANIFESTATION; SKIN PRURITUS; TREATMENT OUTCOME; URTICARIA;

ACETAMINOPHEN; ACETYLCYSTEINE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIDOTES; CANADA; CHILD; COHORT STUDIES; CRITICAL PATHWAYS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICAL SCAVENGERS; HEPATITIS, TOXIC; HUMANS; INFUSIONS, INTRAVENOUS; MALE; OVERDOSE; RETROSPECTIVE STUDIES; RISK; UNITED STATES; YOUNG ADULT;

EID: 70349139532     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.05.010     Document Type: Article

References (40)

1. Bronstein A.C., Spyker D., Cantilena L.R., et al. 2007 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th annual report. Clin Toxicol. 46 (2008) 927-1057
2. Larson A.M., Polson J., Fontana R.J., et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42 (2005) 1364-1372
3. Smilkstein M.J., Knapp G.L., Kulig K.W., et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the National Multicenter Study (1976 to 1985). N Engl J Med. 319 (1988) 1557-1562
4. Prescott L.F., Illingworth R.N., Critchley J.A., et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 2 (1979) 1097-1100
5. Buckley N.A., Whyte I.M., O'Connell D.L., et al. Oral or intravenous N-acetylcysteine. Which is the treatment of choice for acetaminophen (paracetamol) poisoning?. J Toxicol Clin Toxicol. 37 (1999) 759-767
6. Brok J., Buckley N., and Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 3 (2006) CD003328
7. Culley C.M., and Krenzelok E.P. A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective. Toxicol Rev. 24 (2005) 131-143
8. Smith S.W., Howland M.A., Hoffman R.S., et al. Altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-acetylcysteine therapy. Ann Pharmacother. 42 (2008) 1333-1339
9. Sivilotti M.L., Yarema M.C., Juurlink D.N., et al. A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med. 46 (2005) 263-271
10. Rumack B.H., Peterson R.C., Koch G.G., et al. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 141 (1981) 380-385
11. Rumack B.H., and Peterson R.G. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 62 (1978) 898-903
12. Peterson R.G., and Rumack B.H. Age as a variable in acetaminophen overdose. Arch Intern Med. 141 (1981) 390-393
13. Waring W.S., Stephen A.F., Malkowska A.M., et al. Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med. 15 (2008) 54-58
14. Myers R.P., Li B., and Shaheen A.A. Emergency department visits for acetaminophen overdose: a Canadian population-based epidemiologic study (1997-2002). CJEM 9 (2007) 267-274
15. Waring W.S., Stephen A.F., Robinson O.D., et al. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol. 46 (2008) 496-500
16. Bauer D.F. Constructing confidence sets using rank statistics. J Am Stat Assoc. 67 (1972) 687-690
17. Nguyen G.C., Sam J., and Thuluvath P.J. Hepatitis C is a predictor of acute liver injury among hospitalizations for acute acetaminophen overdose in the United States: a nationwide analysis. Hepatology 48 (2008) 1336-1341
18. Gilbert E.H., Lowenstein S., Koziol-McLean J., et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med. 27 (1996) 305-308
19. Worster A., Bledsoe R.D., Cleve P., et al. Reassessing the methods of medical record review studies in emergency medicine research. Ann Emerg Med. 45 (2005) 448-451
20. Prescott L., Roscoe P., Wright N., et al. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 297 (1971) 519-522
21. Kobrinsky N.L., Hartfield D., Horner H., et al. Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue. Cancer Invest. 14 (1996) 202-210
22. Whyte I.M., Francis B., and Dawson A.H. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin. 23 (2007) 2359-2368
23. Prescott L.F., Donovan J.W., Jarvie D.R., et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol. 37 (1989) 501-506
24. Ekins B.R., Ford D.C., Thompson M.I., et al. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med. 5 (1987) 483-487
25. Chamberlain J.M., Gorman R.L., Oderda G.M., et al. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine?. Ann Emerg Med. 22 (1993) 1398-1402
26. Renzi F.P., Donovan J.W., Martin T.G., et al. Concomitant use of activated charcoal and N-acetylcysteine. Ann Emerg Med. 14 (1985) 568-572
27. Miller M.A., Navarro M., Bird S.B., et al. Antiemetic use in acetaminophen poisoning: how does the route of N-acetylcysteine administration affect utilization?. J Med Toxicol. 3 (2007) 152-156
28. Mitchell J.R., Jollow D.J., and Potter W.Z. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 187 (1973) 211-217
29. Rumack B.H. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 40 (2002) 3-20
30. Betten D., Cantrell F., Thomas S., et al. A prospective evaluation of shortened course oral N-acetylcysteine for the treatment of acute acetaminophen poisoning. Ann Emerg Med. 50 (2007) 272-279
31. Woo O.F., Mueller P.D., Olson K.R., et al. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med. 35 (2000) 363-368
32. Dart R., and Rumack B.H. Patient-tailored acetylcysteine administration. Ann Emerg Med. 50 (2007) 280-281
33. Schwartz EA, Hayes BD, Samiento KF. Development of hepatic failure despite use of intravenous acetylcysteine after a massive ingestion of acetaminophen and diphenhydramine. Ann Emerg Med. doi: 10.1016/j.annemergmed.2008.10.001.
34. Smilkstein M.J., Bronstein A.C., Linden C., et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med. 20 (1991) 1058-1063
35. Keays R., Harrison P.M., Wendon J.A., et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 303 (1991) 1026-1029
36. Yip L., Dart R.C., and Hurlbut K.M. Intravenous administration of oral N-acetylcysteine. Crit Care Med. 26 (1998) 40-43
37. Kerr F., Dawson A., Whyte I.M., et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med. 45 (2005) 402-408
38. Schmidt L.E., and Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol. 51 (2001) 87-91
39. Lynch R.M., and Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs. 12 (2004) 10-15
40. Pakravan N., Waring W.S., Sharma S., et al. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol. 46 (2008) 697-702